Shareholder Update Letter

  • 15 January 2017

January 15, 2017

 

Happy New Year from ProLung!

2016 has been a spectacular year.

To achieve our research goals more rapidly, we assembled the most extensive team of clinical investigators of lung cancer in pulmonology.

This speeds the […]

University of Liverpool Lung Cancer Research

  • 3 June 2016

Lung cancer survival rate increases by 73% if caught early
A major lung cancer screening trial, conducted by experts at the University of Liverpool, has found
that patients with a high risk of
developing lung cancer can be identified
with early stage disease […]

ProLungdx Announces Todd Morgan as Chairman of the Board

  • 19 May 2016

Salt Lake City, Utah, May 19, 2016 – Fresh Medical Laboratories, Inc, doing business as ProLungdx™, announced today that its board has appointed Todd Morgan as Chairman of the Board of Directors.  Mr. Morgan […]

ProLung study presented at IASLC 2015 Conference

  • 22 September 2015

September 22, 2015, Salt Lake City, Utah – A study comparing results from the ProLung EPN scan to the results of PET scans was presented at the 16th World Conference on Lung Cancer in Denver, […]

Dr. Jeffrey S. O’Driscoll joins Board of Directors

  • 21 August 2015

August 20, 2015, Salt Lake City Utah – The Board of Directors of the Company appointed Jeffrey S. O’Driscoll as a director of the Company.  Dr. O’Driscoll has practiced as an emergency physician since 1992.  He started […]

ProLung names Clark Campbell as Chairman of the Board

  • 17 June 2014

September 11, 2012, Salt Lake City, Utah—The medical technology company, ProLung, today announced the naming current board member Clark A. Campbell, Ph.D. as its new Chairman, replacing William A. Fresh, who continues as a […]